Copyright
©The Author(s) 2023.
World J Gastrointest Oncol. Feb 15, 2023; 15(2): 286-302
Published online Feb 15, 2023. doi: 10.4251/wjgo.v15.i2.286
Published online Feb 15, 2023. doi: 10.4251/wjgo.v15.i2.286
Figure 7 Cancerous inhibitor of protein phosphatase 2A affected protein kinase B phosphorylation in human gastric cancer cells.
MKN-45 and AGS cells were transfected with the control small interfering RNA (siRNA) or cancerous inhibitor of protein phosphatase 2A (CIP2A) siRNA for 48 h. A: Immunoblotting was used to analyze the indicated protein expression; B and C: The CIP2A (B) and phosphorylated protein kinase B (p-Akt) (C) protein levels were quantified using a spectrophotometer. The results consisted of three independent tests. bP < 0.01. Akt: Protein kinase B.
- Citation: Zhao YX, Ma LB, Yang Z, Wang F, Wang HY, Dang JY. Cancerous inhibitor of protein phosphatase 2A enhances chemoresistance of gastric cancer cells to oxaliplatin. World J Gastrointest Oncol 2023; 15(2): 286-302
- URL: https://www.wjgnet.com/1948-5204/full/v15/i2/286.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v15.i2.286